Andrea Marchetto’s passion and expertise lie in exploring and characterizing the ever-changing interactions between microbial communities and humans, with the aim of improving our symbiotic relationships.
Motivated by this curiosity, Andrea Marchetto completed a Bachelor’s degree in Biotechnology at the University of Turin and a Master’s degree in Biomedical Omics at the University of Milan. During this time, he worked on interactions between the microbiome, lifestyle, and biochemistry, with particular attention to translating this knowledge into human-centered benefits.
He then continued working in the field of microbiota and cancer immunotherapy at the European Institute of Oncology (IEO) in Milan, studying the interaction between the gut microbiome and colorectal cancer.
Since 2023, he has been a PhD student in the Innovation Thérapeutique du Fondamental à l’Appliqué (ITFA) doctoral school at Université Paris-Saclay. His thesis examines the ecotoxic effects of endocrine-disrupting chemicals (EDCs) on the human microbiota and their role in shaping the functional composition of bacterial communities. By dissecting bacterial detoxification strategies and mechanisms of resilience, he aims to predict the possible effects of exposure on host health in sensitive contexts such as early life or hormone-driven pathologies.
Andrea has experience in both anaerobic and aerobic microbiology and uses a multi-omics approach (including metagenomics, metatranscriptomics, metaproteomics, and metabolomics) together with a broad range of bioinformatic and data analysis tools to interpret complex datasets. His research centers on microbial ecology within complex bacterial communities, from controlled microcosms to synthetic communities designed to replicate real-world biological systems.
